Tetsuaki Shoji et al. found that in cisplatin-resistant lung cancer cell line models, the transcription levels of PSMB8 and PSMB9 were highly expressed, and the protein expression levels were also significantly increased. This evidence concerns the gene PSMB9 and lung carcinoma.